nodes	percent_of_prediction	percent_of_DWPC	metapath
Flutamide—Nilutamide—prostate cancer	0.24	1	CrCtD
Flutamide—Androgen Receptor Antagonists—Bicalutamide—prostate cancer	0.158	0.5	CiPCiCtD
Flutamide—Androgen Receptor Antagonists—Nilutamide—prostate cancer	0.158	0.5	CiPCiCtD
Flutamide—Nitisinone—Nilutamide—prostate cancer	0.139	1	CrCrCtD
Flutamide—AHR—prostate cancer	0.0366	0.298	CbGaD
Flutamide—CYP1B1—prostate cancer	0.021	0.171	CbGaD
Flutamide—AR—Nilutamide—prostate cancer	0.0195	0.164	CbGbCtD
Flutamide—AR—Bicalutamide—prostate cancer	0.0195	0.164	CbGbCtD
Flutamide—AR—prostate cancer	0.0184	0.15	CbGaD
Flutamide—CYP3A5—prostate cancer	0.0167	0.136	CbGaD
Flutamide—CYP2C19—prostate cancer	0.0114	0.0928	CbGaD
Flutamide—CYP1A1—prostate cancer	0.0114	0.0925	CbGaD
Flutamide—CYP1B1—Estrone—prostate cancer	0.0101	0.0852	CbGbCtD
Flutamide—CYP3A4—prostate cancer	0.00725	0.059	CbGaD
Flutamide—AR—Estradiol—prostate cancer	0.00672	0.0566	CbGbCtD
Flutamide—CYP1B1—Mitoxantrone—prostate cancer	0.00601	0.0506	CbGbCtD
Flutamide—CYP1B1—Estradiol—prostate cancer	0.00581	0.0489	CbGbCtD
Flutamide—CYP1A1—Estrone—prostate cancer	0.00444	0.0374	CbGbCtD
Flutamide—CYP2C19—Nilutamide—prostate cancer	0.00358	0.0302	CbGbCtD
Flutamide—CYP2C19—Bicalutamide—prostate cancer	0.00358	0.0302	CbGbCtD
Flutamide—CYP1B1—Docetaxel—prostate cancer	0.00347	0.0292	CbGbCtD
Flutamide—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0033	0.0278	CbGbCtD
Flutamide—CYP3A5—Cabazitaxel—prostate cancer	0.00272	0.0229	CbGbCtD
Flutamide—CYP3A5—Estrone—prostate cancer	0.00266	0.0224	CbGbCtD
Flutamide—CYP1B1—Doxorubicin—prostate cancer	0.00259	0.0218	CbGbCtD
Flutamide—CYP1A1—Estradiol—prostate cancer	0.00255	0.0215	CbGbCtD
Flutamide—CYP1A2—Estrone—prostate cancer	0.00198	0.0167	CbGbCtD
Flutamide—CYP3A4—Bicalutamide—prostate cancer	0.00173	0.0146	CbGbCtD
Flutamide—CYP3A4—Estramustine—prostate cancer	0.00161	0.0136	CbGbCtD
Flutamide—CYP3A5—Estradiol—prostate cancer	0.00153	0.0129	CbGbCtD
Flutamide—CYP3A4—Abiraterone—prostate cancer	0.00144	0.0121	CbGbCtD
Flutamide—CYP1A2—Conjugated Estrogens—prostate cancer	0.0013	0.0109	CbGbCtD
Flutamide—CYP2C19—Estradiol—prostate cancer	0.00123	0.0104	CbGbCtD
Flutamide—CYP1A2—Estradiol—prostate cancer	0.00114	0.00959	CbGbCtD
Flutamide—CYP3A4—Cabazitaxel—prostate cancer	0.00106	0.00895	CbGbCtD
Flutamide—CYP2C19—Prednisone—prostate cancer	0.00106	0.00894	CbGbCtD
Flutamide—CYP3A4—Estrone—prostate cancer	0.00104	0.00875	CbGbCtD
Flutamide—CYP3A5—Etoposide—prostate cancer	0.000998	0.00841	CbGbCtD
Flutamide—AR—penis—prostate cancer	0.00093	0.126	CbGeAlD
Flutamide—CYP3A4—Ethinyl Estradiol—prostate cancer	0.000925	0.0078	CbGbCtD
Flutamide—CYP3A5—Docetaxel—prostate cancer	0.000913	0.0077	CbGbCtD
Flutamide—AR—semen—prostate cancer	0.000886	0.12	CbGeAlD
Flutamide—CYP1A2—Etoposide—prostate cancer	0.000743	0.00626	CbGbCtD
Flutamide—CYP3A4—Conjugated Estrogens—prostate cancer	0.000679	0.00572	CbGbCtD
Flutamide—CYP3A4—Mitoxantrone—prostate cancer	0.000617	0.0052	CbGbCtD
Flutamide—CYP3A4—Estradiol—prostate cancer	0.000596	0.00502	CbGbCtD
Flutamide—CYP2C19—urine—prostate cancer	0.000573	0.0776	CbGeAlD
Flutamide—CYP3A4—Prednisone—prostate cancer	0.000513	0.00432	CbGbCtD
Flutamide—CYP1A2—urine—prostate cancer	0.000468	0.0634	CbGeAlD
Flutamide—AHR—prostate gland—prostate cancer	0.00045	0.061	CbGeAlD
Flutamide—CYP3A4—Etoposide—prostate cancer	0.000389	0.00328	CbGbCtD
Flutamide—AHR—seminal vesicle—prostate cancer	0.000381	0.0516	CbGeAlD
Flutamide—CYP3A4—Docetaxel—prostate cancer	0.000356	0.003	CbGbCtD
Flutamide—CYP3A4—urine—prostate cancer	0.000339	0.0459	CbGeAlD
Flutamide—AHR—urethra—prostate cancer	0.000301	0.0408	CbGeAlD
Flutamide—CYP3A4—Doxorubicin—prostate cancer	0.000266	0.00224	CbGbCtD
Flutamide—Nilutamide—AR—prostate cancer	0.000252	0.618	CrCbGaD
Flutamide—CYP1B1—prostate gland—prostate cancer	0.000234	0.0318	CbGeAlD
Flutamide—AHR—bone marrow—prostate cancer	0.000232	0.0314	CbGeAlD
Flutamide—AR—prostate gland—prostate cancer	0.000222	0.0301	CbGeAlD
Flutamide—AHR—testis—prostate cancer	0.000198	0.0269	CbGeAlD
Flutamide—AR—seminal vesicle—prostate cancer	0.000188	0.0254	CbGeAlD
Flutamide—AR—epithelium—prostate cancer	0.000163	0.0221	CbGeAlD
Flutamide—CYP3A5—prostate gland—prostate cancer	0.000162	0.0219	CbGeAlD
Flutamide—CYP1B1—renal system—prostate cancer	0.00016	0.0216	CbGeAlD
Flutamide—Nilutamide—CYP2C19—prostate cancer	0.000156	0.382	CrCbGaD
Flutamide—AR—renal system—prostate cancer	0.000151	0.0205	CbGeAlD
Flutamide—AR—urethra—prostate cancer	0.000149	0.0201	CbGeAlD
Flutamide—AHR—lymph node—prostate cancer	0.000144	0.0195	CbGeAlD
Flutamide—CYP1A1—epithelium—prostate cancer	0.000122	0.0165	CbGeAlD
Flutamide—CYP1A2—renal system—prostate cancer	0.000115	0.0155	CbGeAlD
Flutamide—CYP1A1—renal system—prostate cancer	0.000113	0.0153	CbGeAlD
Flutamide—CYP1A1—urethra—prostate cancer	0.000111	0.015	CbGeAlD
Flutamide—CYP3A5—renal system—prostate cancer	0.00011	0.015	CbGeAlD
Flutamide—CYP1B1—testis—prostate cancer	0.000103	0.014	CbGeAlD
Flutamide—AR—testis—prostate cancer	9.78e-05	0.0132	CbGeAlD
Flutamide—CYP3A4—renal system—prostate cancer	8.29e-05	0.0112	CbGeAlD
Flutamide—CYP1B1—lymph node—prostate cancer	7.49e-05	0.0101	CbGeAlD
Flutamide—AR—lymph node—prostate cancer	7.09e-05	0.0096	CbGeAlD
Flutamide—CYP1A1—lymph node—prostate cancer	5.29e-05	0.00717	CbGeAlD
Flutamide—Hot flush—Epirubicin—prostate cancer	1.79e-05	0.000576	CcSEcCtD
Flutamide—Increased appetite—Epirubicin—prostate cancer	1.79e-05	0.000574	CcSEcCtD
Flutamide—Diabetes mellitus—Doxorubicin—prostate cancer	1.79e-05	0.000573	CcSEcCtD
Flutamide—Confusional state—Mitoxantrone—prostate cancer	1.78e-05	0.000573	CcSEcCtD
Flutamide—Menopausal symptoms—Epirubicin—prostate cancer	1.78e-05	0.000571	CcSEcCtD
Flutamide—Haematuria—Capecitabine—prostate cancer	1.77e-05	0.000568	CcSEcCtD
Flutamide—Oedema—Mitoxantrone—prostate cancer	1.77e-05	0.000568	CcSEcCtD
Flutamide—Dermatitis bullous—Epirubicin—prostate cancer	1.76e-05	0.000564	CcSEcCtD
Flutamide—Thrombocytopenia—Mitoxantrone—prostate cancer	1.73e-05	0.000556	CcSEcCtD
Flutamide—Nausea—Ethinyl Estradiol—prostate cancer	1.73e-05	0.000555	CcSEcCtD
Flutamide—Hepatitis—Docetaxel—prostate cancer	1.72e-05	0.000553	CcSEcCtD
Flutamide—Asthenia—Goserelin—prostate cancer	1.72e-05	0.000552	CcSEcCtD
Flutamide—Skin disorder—Mitoxantrone—prostate cancer	1.72e-05	0.000552	CcSEcCtD
Flutamide—Insomnia—Estradiol—prostate cancer	1.72e-05	0.000552	CcSEcCtD
Flutamide—Erectile dysfunction—Prednisone—prostate cancer	1.71e-05	0.000549	CcSEcCtD
Flutamide—Asthenia—Conjugated Estrogens—prostate cancer	1.7e-05	0.000547	CcSEcCtD
Flutamide—Oedema peripheral—Docetaxel—prostate cancer	1.7e-05	0.000545	CcSEcCtD
Flutamide—Pruritus—Goserelin—prostate cancer	1.69e-05	0.000544	CcSEcCtD
Flutamide—Somnolence—Estradiol—prostate cancer	1.69e-05	0.000542	CcSEcCtD
Flutamide—Anorexia—Mitoxantrone—prostate cancer	1.69e-05	0.000542	CcSEcCtD
Flutamide—Pruritus—Conjugated Estrogens—prostate cancer	1.68e-05	0.000539	CcSEcCtD
Flutamide—Hyperglycaemia—Prednisone—prostate cancer	1.67e-05	0.000537	CcSEcCtD
Flutamide—Ill-defined disorder—Etoposide—prostate cancer	1.67e-05	0.000537	CcSEcCtD
Flutamide—Hepatitis—Capecitabine—prostate cancer	1.67e-05	0.000535	CcSEcCtD
Flutamide—Anaemia—Etoposide—prostate cancer	1.67e-05	0.000535	CcSEcCtD
Flutamide—Hot flush—Doxorubicin—prostate cancer	1.66e-05	0.000533	CcSEcCtD
Flutamide—Increased appetite—Doxorubicin—prostate cancer	1.65e-05	0.000531	CcSEcCtD
Flutamide—Decreased appetite—Estradiol—prostate cancer	1.65e-05	0.00053	CcSEcCtD
Flutamide—Menopausal symptoms—Doxorubicin—prostate cancer	1.65e-05	0.000529	CcSEcCtD
Flutamide—Oedema peripheral—Capecitabine—prostate cancer	1.64e-05	0.000527	CcSEcCtD
Flutamide—Diarrhoea—Goserelin—prostate cancer	1.64e-05	0.000526	CcSEcCtD
Flutamide—Fatigue—Estradiol—prostate cancer	1.64e-05	0.000526	CcSEcCtD
Flutamide—Malaise—Etoposide—prostate cancer	1.63e-05	0.000522	CcSEcCtD
Flutamide—Dermatitis bullous—Doxorubicin—prostate cancer	1.63e-05	0.000522	CcSEcCtD
Flutamide—Constipation—Estradiol—prostate cancer	1.62e-05	0.000521	CcSEcCtD
Flutamide—Diarrhoea—Conjugated Estrogens—prostate cancer	1.62e-05	0.000521	CcSEcCtD
Flutamide—Leukopenia—Etoposide—prostate cancer	1.61e-05	0.000518	CcSEcCtD
Flutamide—Dizziness—Goserelin—prostate cancer	1.58e-05	0.000509	CcSEcCtD
Flutamide—Somnolence—Mitoxantrone—prostate cancer	1.57e-05	0.000505	CcSEcCtD
Flutamide—Dizziness—Conjugated Estrogens—prostate cancer	1.57e-05	0.000504	CcSEcCtD
Flutamide—Feeling abnormal—Estradiol—prostate cancer	1.57e-05	0.000502	CcSEcCtD
Flutamide—Hypertension—Etoposide—prostate cancer	1.56e-05	0.0005	CcSEcCtD
Flutamide—Decreased appetite—Mitoxantrone—prostate cancer	1.54e-05	0.000494	CcSEcCtD
Flutamide—Fatigue—Mitoxantrone—prostate cancer	1.53e-05	0.00049	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—prostate cancer	1.52e-05	0.00049	CcSEcCtD
Flutamide—Vomiting—Goserelin—prostate cancer	1.52e-05	0.000489	CcSEcCtD
Flutamide—Discomfort—Etoposide—prostate cancer	1.52e-05	0.000487	CcSEcCtD
Flutamide—Constipation—Mitoxantrone—prostate cancer	1.51e-05	0.000486	CcSEcCtD
Flutamide—Toxic epidermal necrolysis—Epirubicin—prostate cancer	1.51e-05	0.000485	CcSEcCtD
Flutamide—Aspartate aminotransferase increased—Epirubicin—prostate cancer	1.51e-05	0.000485	CcSEcCtD
Flutamide—Rash—Goserelin—prostate cancer	1.51e-05	0.000485	CcSEcCtD
Flutamide—Dermatitis—Goserelin—prostate cancer	1.51e-05	0.000485	CcSEcCtD
Flutamide—Vomiting—Conjugated Estrogens—prostate cancer	1.51e-05	0.000484	CcSEcCtD
Flutamide—Headache—Goserelin—prostate cancer	1.5e-05	0.000482	CcSEcCtD
Flutamide—Erythema—Docetaxel—prostate cancer	1.5e-05	0.000481	CcSEcCtD
Flutamide—Rash—Conjugated Estrogens—prostate cancer	1.5e-05	0.00048	CcSEcCtD
Flutamide—Dermatitis—Conjugated Estrogens—prostate cancer	1.49e-05	0.00048	CcSEcCtD
Flutamide—Headache—Conjugated Estrogens—prostate cancer	1.49e-05	0.000477	CcSEcCtD
Flutamide—Confusional state—Etoposide—prostate cancer	1.48e-05	0.000477	CcSEcCtD
Flutamide—Feeling abnormal—Mitoxantrone—prostate cancer	1.46e-05	0.000468	CcSEcCtD
Flutamide—Erythema—Capecitabine—prostate cancer	1.45e-05	0.000466	CcSEcCtD
Flutamide—Thrombocytopenia—Etoposide—prostate cancer	1.44e-05	0.000463	CcSEcCtD
Flutamide—Skin disorder—Etoposide—prostate cancer	1.43e-05	0.000459	CcSEcCtD
Flutamide—Nausea—Goserelin—prostate cancer	1.42e-05	0.000457	CcSEcCtD
Flutamide—Nausea—Conjugated Estrogens—prostate cancer	1.41e-05	0.000453	CcSEcCtD
Flutamide—Anorexia—Etoposide—prostate cancer	1.4e-05	0.00045	CcSEcCtD
Flutamide—Aspartate aminotransferase increased—Doxorubicin—prostate cancer	1.4e-05	0.000449	CcSEcCtD
Flutamide—Toxic epidermal necrolysis—Doxorubicin—prostate cancer	1.4e-05	0.000449	CcSEcCtD
Flutamide—Anaemia—Docetaxel—prostate cancer	1.39e-05	0.000445	CcSEcCtD
Flutamide—Asthenia—Estradiol—prostate cancer	1.36e-05	0.000437	CcSEcCtD
Flutamide—Ill-defined disorder—Capecitabine—prostate cancer	1.35e-05	0.000432	CcSEcCtD
Flutamide—Pruritus—Estradiol—prostate cancer	1.34e-05	0.000431	CcSEcCtD
Flutamide—Leukopenia—Docetaxel—prostate cancer	1.34e-05	0.000431	CcSEcCtD
Flutamide—Anaemia—Capecitabine—prostate cancer	1.34e-05	0.000431	CcSEcCtD
Flutamide—Photosensitivity reaction—Epirubicin—prostate cancer	1.32e-05	0.000425	CcSEcCtD
Flutamide—Hyperglycaemia—Epirubicin—prostate cancer	1.31e-05	0.00042	CcSEcCtD
Flutamide—Malaise—Capecitabine—prostate cancer	1.31e-05	0.00042	CcSEcCtD
Flutamide—Somnolence—Etoposide—prostate cancer	1.31e-05	0.00042	CcSEcCtD
Flutamide—Diarrhoea—Estradiol—prostate cancer	1.3e-05	0.000417	CcSEcCtD
Flutamide—Leukopenia—Capecitabine—prostate cancer	1.3e-05	0.000417	CcSEcCtD
Flutamide—Hypertension—Docetaxel—prostate cancer	1.29e-05	0.000415	CcSEcCtD
Flutamide—Drowsiness—Epirubicin—prostate cancer	1.29e-05	0.000415	CcSEcCtD
Flutamide—Erythema—Prednisone—prostate cancer	1.29e-05	0.000415	CcSEcCtD
Flutamide—Decreased appetite—Etoposide—prostate cancer	1.28e-05	0.000411	CcSEcCtD
Flutamide—Asthenia—Mitoxantrone—prostate cancer	1.27e-05	0.000408	CcSEcCtD
Flutamide—Fatigue—Etoposide—prostate cancer	1.27e-05	0.000407	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	1.27e-05	0.000407	CcSEcCtD
Flutamide—Jaundice—Epirubicin—prostate cancer	1.26e-05	0.000405	CcSEcCtD
Flutamide—Constipation—Etoposide—prostate cancer	1.26e-05	0.000404	CcSEcCtD
Flutamide—Dizziness—Estradiol—prostate cancer	1.26e-05	0.000403	CcSEcCtD
Flutamide—Hypertension—Capecitabine—prostate cancer	1.25e-05	0.000402	CcSEcCtD
Flutamide—Haematuria—Epirubicin—prostate cancer	1.23e-05	0.000396	CcSEcCtD
Flutamide—Confusional state—Docetaxel—prostate cancer	1.23e-05	0.000396	CcSEcCtD
Flutamide—Anxiety—Capecitabine—prostate cancer	1.23e-05	0.000395	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	1.23e-05	0.000394	CcSEcCtD
Flutamide—Photosensitivity reaction—Doxorubicin—prostate cancer	1.23e-05	0.000393	CcSEcCtD
Flutamide—Oedema—Docetaxel—prostate cancer	1.22e-05	0.000393	CcSEcCtD
Flutamide—Discomfort—Capecitabine—prostate cancer	1.22e-05	0.000392	CcSEcCtD
Flutamide—Feeling abnormal—Etoposide—prostate cancer	1.21e-05	0.000389	CcSEcCtD
Flutamide—Hyperglycaemia—Doxorubicin—prostate cancer	1.21e-05	0.000389	CcSEcCtD
Flutamide—Diarrhoea—Mitoxantrone—prostate cancer	1.21e-05	0.000389	CcSEcCtD
Flutamide—Vomiting—Estradiol—prostate cancer	1.21e-05	0.000388	CcSEcCtD
Flutamide—Ill-defined disorder—Prednisone—prostate cancer	1.2e-05	0.000385	CcSEcCtD
Flutamide—Thrombocytopenia—Docetaxel—prostate cancer	1.2e-05	0.000385	CcSEcCtD
Flutamide—Rash—Estradiol—prostate cancer	1.2e-05	0.000384	CcSEcCtD
Flutamide—Drowsiness—Doxorubicin—prostate cancer	1.2e-05	0.000384	CcSEcCtD
Flutamide—Dermatitis—Estradiol—prostate cancer	1.2e-05	0.000384	CcSEcCtD
Flutamide—Anaemia—Prednisone—prostate cancer	1.19e-05	0.000384	CcSEcCtD
Flutamide—Confusional state—Capecitabine—prostate cancer	1.19e-05	0.000383	CcSEcCtD
Flutamide—Headache—Estradiol—prostate cancer	1.19e-05	0.000382	CcSEcCtD
Flutamide—Skin disorder—Docetaxel—prostate cancer	1.19e-05	0.000381	CcSEcCtD
Flutamide—Oedema—Capecitabine—prostate cancer	1.18e-05	0.00038	CcSEcCtD
Flutamide—Jaundice—Doxorubicin—prostate cancer	1.17e-05	0.000375	CcSEcCtD
Flutamide—Anorexia—Docetaxel—prostate cancer	1.17e-05	0.000374	CcSEcCtD
Flutamide—Malaise—Prednisone—prostate cancer	1.17e-05	0.000374	CcSEcCtD
Flutamide—Hepatitis—Epirubicin—prostate cancer	1.16e-05	0.000373	CcSEcCtD
Flutamide—Thrombocytopenia—Capecitabine—prostate cancer	1.16e-05	0.000372	CcSEcCtD
Flutamide—Skin disorder—Capecitabine—prostate cancer	1.15e-05	0.000369	CcSEcCtD
Flutamide—Oedema peripheral—Epirubicin—prostate cancer	1.14e-05	0.000367	CcSEcCtD
Flutamide—Haematuria—Doxorubicin—prostate cancer	1.14e-05	0.000366	CcSEcCtD
Flutamide—Anorexia—Capecitabine—prostate cancer	1.13e-05	0.000362	CcSEcCtD
Flutamide—Nausea—Estradiol—prostate cancer	1.13e-05	0.000362	CcSEcCtD
Flutamide—Vomiting—Mitoxantrone—prostate cancer	1.13e-05	0.000361	CcSEcCtD
Flutamide—Hypertension—Prednisone—prostate cancer	1.12e-05	0.000358	CcSEcCtD
Flutamide—Rash—Mitoxantrone—prostate cancer	1.12e-05	0.000358	CcSEcCtD
Flutamide—Dermatitis—Mitoxantrone—prostate cancer	1.11e-05	0.000358	CcSEcCtD
Flutamide—Headache—Mitoxantrone—prostate cancer	1.11e-05	0.000356	CcSEcCtD
Flutamide—Insomnia—Docetaxel—prostate cancer	1.11e-05	0.000355	CcSEcCtD
Flutamide—Anxiety—Prednisone—prostate cancer	1.1e-05	0.000352	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	1.09e-05	0.000351	CcSEcCtD
Flutamide—Somnolence—Docetaxel—prostate cancer	1.09e-05	0.000349	CcSEcCtD
Flutamide—Discomfort—Prednisone—prostate cancer	1.09e-05	0.000349	CcSEcCtD
Flutamide—Hepatitis—Doxorubicin—prostate cancer	1.07e-05	0.000345	CcSEcCtD
Flutamide—Insomnia—Capecitabine—prostate cancer	1.07e-05	0.000344	CcSEcCtD
Flutamide—Decreased appetite—Docetaxel—prostate cancer	1.06e-05	0.000341	CcSEcCtD
Flutamide—Oedema peripheral—Doxorubicin—prostate cancer	1.06e-05	0.00034	CcSEcCtD
Flutamide—Asthenia—Etoposide—prostate cancer	1.06e-05	0.000339	CcSEcCtD
Flutamide—Oedema—Prednisone—prostate cancer	1.05e-05	0.000339	CcSEcCtD
Flutamide—Fatigue—Docetaxel—prostate cancer	1.05e-05	0.000339	CcSEcCtD
Flutamide—Nausea—Mitoxantrone—prostate cancer	1.05e-05	0.000337	CcSEcCtD
Flutamide—Constipation—Docetaxel—prostate cancer	1.05e-05	0.000336	CcSEcCtD
Flutamide—Pruritus—Etoposide—prostate cancer	1.04e-05	0.000334	CcSEcCtD
Flutamide—Decreased appetite—Capecitabine—prostate cancer	1.03e-05	0.000331	CcSEcCtD
Flutamide—Skin disorder—Prednisone—prostate cancer	1.02e-05	0.000329	CcSEcCtD
Flutamide—Fatigue—Capecitabine—prostate cancer	1.02e-05	0.000328	CcSEcCtD
Flutamide—Constipation—Capecitabine—prostate cancer	1.01e-05	0.000325	CcSEcCtD
Flutamide—Erythema—Epirubicin—prostate cancer	1.01e-05	0.000325	CcSEcCtD
Flutamide—Feeling abnormal—Docetaxel—prostate cancer	1.01e-05	0.000324	CcSEcCtD
Flutamide—Diarrhoea—Etoposide—prostate cancer	1.01e-05	0.000323	CcSEcCtD
Flutamide—Anorexia—Prednisone—prostate cancer	1.01e-05	0.000323	CcSEcCtD
Flutamide—Tension—Epirubicin—prostate cancer	9.92e-06	0.000319	CcSEcCtD
Flutamide—Nervousness—Epirubicin—prostate cancer	9.82e-06	0.000315	CcSEcCtD
Flutamide—Feeling abnormal—Capecitabine—prostate cancer	9.76e-06	0.000313	CcSEcCtD
Flutamide—Dizziness—Etoposide—prostate cancer	9.73e-06	0.000313	CcSEcCtD
Flutamide—Insomnia—Prednisone—prostate cancer	9.54e-06	0.000306	CcSEcCtD
Flutamide—Ill-defined disorder—Epirubicin—prostate cancer	9.38e-06	0.000301	CcSEcCtD
Flutamide—Vomiting—Etoposide—prostate cancer	9.36e-06	0.0003	CcSEcCtD
Flutamide—Erythema—Doxorubicin—prostate cancer	9.35e-06	0.0003	CcSEcCtD
Flutamide—Anaemia—Epirubicin—prostate cancer	9.34e-06	0.0003	CcSEcCtD
Flutamide—Rash—Etoposide—prostate cancer	9.28e-06	0.000298	CcSEcCtD
Flutamide—Dermatitis—Etoposide—prostate cancer	9.27e-06	0.000298	CcSEcCtD
Flutamide—Headache—Etoposide—prostate cancer	9.22e-06	0.000296	CcSEcCtD
Flutamide—Tension—Doxorubicin—prostate cancer	9.18e-06	0.000295	CcSEcCtD
Flutamide—Decreased appetite—Prednisone—prostate cancer	9.17e-06	0.000294	CcSEcCtD
Flutamide—Malaise—Epirubicin—prostate cancer	9.12e-06	0.000293	CcSEcCtD
Flutamide—Fatigue—Prednisone—prostate cancer	9.1e-06	0.000292	CcSEcCtD
Flutamide—Nervousness—Doxorubicin—prostate cancer	9.09e-06	0.000292	CcSEcCtD
Flutamide—Leukopenia—Epirubicin—prostate cancer	9.05e-06	0.000291	CcSEcCtD
Flutamide—Constipation—Prednisone—prostate cancer	9.02e-06	0.00029	CcSEcCtD
Flutamide—Asthenia—Docetaxel—prostate cancer	8.78e-06	0.000282	CcSEcCtD
Flutamide—Nausea—Etoposide—prostate cancer	8.74e-06	0.000281	CcSEcCtD
Flutamide—Hypertension—Epirubicin—prostate cancer	8.73e-06	0.00028	CcSEcCtD
Flutamide—Feeling abnormal—Prednisone—prostate cancer	8.69e-06	0.000279	CcSEcCtD
Flutamide—Ill-defined disorder—Doxorubicin—prostate cancer	8.68e-06	0.000279	CcSEcCtD
Flutamide—Pruritus—Docetaxel—prostate cancer	8.65e-06	0.000278	CcSEcCtD
Flutamide—Anaemia—Doxorubicin—prostate cancer	8.65e-06	0.000278	CcSEcCtD
Flutamide—Anxiety—Epirubicin—prostate cancer	8.58e-06	0.000275	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	8.55e-06	0.000274	CcSEcCtD
Flutamide—Discomfort—Epirubicin—prostate cancer	8.5e-06	0.000273	CcSEcCtD
Flutamide—Asthenia—Capecitabine—prostate cancer	8.5e-06	0.000273	CcSEcCtD
Flutamide—Malaise—Doxorubicin—prostate cancer	8.44e-06	0.000271	CcSEcCtD
Flutamide—Pruritus—Capecitabine—prostate cancer	8.38e-06	0.000269	CcSEcCtD
Flutamide—Leukopenia—Doxorubicin—prostate cancer	8.37e-06	0.000269	CcSEcCtD
Flutamide—Diarrhoea—Docetaxel—prostate cancer	8.37e-06	0.000269	CcSEcCtD
Flutamide—Confusional state—Epirubicin—prostate cancer	8.32e-06	0.000267	CcSEcCtD
Flutamide—Oedema—Epirubicin—prostate cancer	8.25e-06	0.000265	CcSEcCtD
Flutamide—Diarrhoea—Capecitabine—prostate cancer	8.1e-06	0.00026	CcSEcCtD
Flutamide—Dizziness—Docetaxel—prostate cancer	8.09e-06	0.00026	CcSEcCtD
Flutamide—Thrombocytopenia—Epirubicin—prostate cancer	8.08e-06	0.000259	CcSEcCtD
Flutamide—Hypertension—Doxorubicin—prostate cancer	8.08e-06	0.000259	CcSEcCtD
Flutamide—Skin disorder—Epirubicin—prostate cancer	8.01e-06	0.000257	CcSEcCtD
Flutamide—Anxiety—Doxorubicin—prostate cancer	7.94e-06	0.000255	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	7.91e-06	0.000254	CcSEcCtD
Flutamide—Discomfort—Doxorubicin—prostate cancer	7.87e-06	0.000253	CcSEcCtD
Flutamide—Anorexia—Epirubicin—prostate cancer	7.87e-06	0.000253	CcSEcCtD
Flutamide—Dizziness—Capecitabine—prostate cancer	7.83e-06	0.000251	CcSEcCtD
Flutamide—Vomiting—Docetaxel—prostate cancer	7.78e-06	0.00025	CcSEcCtD
Flutamide—Rash—Docetaxel—prostate cancer	7.71e-06	0.000248	CcSEcCtD
Flutamide—Dermatitis—Docetaxel—prostate cancer	7.71e-06	0.000247	CcSEcCtD
Flutamide—Confusional state—Doxorubicin—prostate cancer	7.7e-06	0.000247	CcSEcCtD
Flutamide—Headache—Docetaxel—prostate cancer	7.66e-06	0.000246	CcSEcCtD
Flutamide—Oedema—Doxorubicin—prostate cancer	7.63e-06	0.000245	CcSEcCtD
Flutamide—Asthenia—Prednisone—prostate cancer	7.57e-06	0.000243	CcSEcCtD
Flutamide—Vomiting—Capecitabine—prostate cancer	7.53e-06	0.000242	CcSEcCtD
Flutamide—Thrombocytopenia—Doxorubicin—prostate cancer	7.48e-06	0.00024	CcSEcCtD
Flutamide—Rash—Capecitabine—prostate cancer	7.47e-06	0.00024	CcSEcCtD
Flutamide—Pruritus—Prednisone—prostate cancer	7.46e-06	0.00024	CcSEcCtD
Flutamide—Insomnia—Epirubicin—prostate cancer	7.46e-06	0.00024	CcSEcCtD
Flutamide—Dermatitis—Capecitabine—prostate cancer	7.46e-06	0.00024	CcSEcCtD
Flutamide—Headache—Capecitabine—prostate cancer	7.42e-06	0.000238	CcSEcCtD
Flutamide—Skin disorder—Doxorubicin—prostate cancer	7.42e-06	0.000238	CcSEcCtD
Flutamide—Somnolence—Epirubicin—prostate cancer	7.34e-06	0.000236	CcSEcCtD
Flutamide—Anorexia—Doxorubicin—prostate cancer	7.28e-06	0.000234	CcSEcCtD
Flutamide—Nausea—Docetaxel—prostate cancer	7.27e-06	0.000233	CcSEcCtD
Flutamide—Diarrhoea—Prednisone—prostate cancer	7.22e-06	0.000232	CcSEcCtD
Flutamide—Decreased appetite—Epirubicin—prostate cancer	7.17e-06	0.00023	CcSEcCtD
Flutamide—Fatigue—Epirubicin—prostate cancer	7.11e-06	0.000228	CcSEcCtD
Flutamide—Constipation—Epirubicin—prostate cancer	7.06e-06	0.000227	CcSEcCtD
Flutamide—Nausea—Capecitabine—prostate cancer	7.04e-06	0.000226	CcSEcCtD
Flutamide—Dizziness—Prednisone—prostate cancer	6.98e-06	0.000224	CcSEcCtD
Flutamide—Insomnia—Doxorubicin—prostate cancer	6.91e-06	0.000222	CcSEcCtD
Flutamide—Feeling abnormal—Epirubicin—prostate cancer	6.8e-06	0.000218	CcSEcCtD
Flutamide—Somnolence—Doxorubicin—prostate cancer	6.79e-06	0.000218	CcSEcCtD
Flutamide—Vomiting—Prednisone—prostate cancer	6.71e-06	0.000215	CcSEcCtD
Flutamide—Rash—Prednisone—prostate cancer	6.65e-06	0.000214	CcSEcCtD
Flutamide—Dermatitis—Prednisone—prostate cancer	6.65e-06	0.000213	CcSEcCtD
Flutamide—Decreased appetite—Doxorubicin—prostate cancer	6.64e-06	0.000213	CcSEcCtD
Flutamide—Headache—Prednisone—prostate cancer	6.61e-06	0.000212	CcSEcCtD
Flutamide—Fatigue—Doxorubicin—prostate cancer	6.58e-06	0.000211	CcSEcCtD
Flutamide—Constipation—Doxorubicin—prostate cancer	6.53e-06	0.00021	CcSEcCtD
Flutamide—Feeling abnormal—Doxorubicin—prostate cancer	6.29e-06	0.000202	CcSEcCtD
Flutamide—Nausea—Prednisone—prostate cancer	6.27e-06	0.000201	CcSEcCtD
Flutamide—Asthenia—Epirubicin—prostate cancer	5.92e-06	0.00019	CcSEcCtD
Flutamide—Pruritus—Epirubicin—prostate cancer	5.84e-06	0.000187	CcSEcCtD
Flutamide—Diarrhoea—Epirubicin—prostate cancer	5.65e-06	0.000181	CcSEcCtD
Flutamide—Asthenia—Doxorubicin—prostate cancer	5.48e-06	0.000176	CcSEcCtD
Flutamide—Dizziness—Epirubicin—prostate cancer	5.46e-06	0.000175	CcSEcCtD
Flutamide—Pruritus—Doxorubicin—prostate cancer	5.4e-06	0.000173	CcSEcCtD
Flutamide—Vomiting—Epirubicin—prostate cancer	5.25e-06	0.000168	CcSEcCtD
Flutamide—Diarrhoea—Doxorubicin—prostate cancer	5.22e-06	0.000168	CcSEcCtD
Flutamide—Rash—Epirubicin—prostate cancer	5.2e-06	0.000167	CcSEcCtD
Flutamide—Dermatitis—Epirubicin—prostate cancer	5.2e-06	0.000167	CcSEcCtD
Flutamide—Headache—Epirubicin—prostate cancer	5.17e-06	0.000166	CcSEcCtD
Flutamide—Dizziness—Doxorubicin—prostate cancer	5.05e-06	0.000162	CcSEcCtD
Flutamide—Nausea—Epirubicin—prostate cancer	4.9e-06	0.000157	CcSEcCtD
Flutamide—Vomiting—Doxorubicin—prostate cancer	4.85e-06	0.000156	CcSEcCtD
Flutamide—Rash—Doxorubicin—prostate cancer	4.81e-06	0.000155	CcSEcCtD
Flutamide—Dermatitis—Doxorubicin—prostate cancer	4.81e-06	0.000154	CcSEcCtD
Flutamide—Headache—Doxorubicin—prostate cancer	4.78e-06	0.000154	CcSEcCtD
Flutamide—Nausea—Doxorubicin—prostate cancer	4.53e-06	0.000146	CcSEcCtD
Flutamide—CYP1A2—Metabolism—HSD3B2—prostate cancer	7.05e-07	2.81e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—NAT2—prostate cancer	7.05e-07	2.81e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—TH—prostate cancer	7.02e-07	2.8e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ACHE—prostate cancer	7.02e-07	2.8e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GSTT1—prostate cancer	7.02e-07	2.8e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GGT1—prostate cancer	7.01e-07	2.79e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	6.98e-07	2.78e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CYP3A4—prostate cancer	6.95e-07	2.77e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CYP2A6—prostate cancer	6.94e-07	2.76e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	6.92e-07	2.75e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	6.91e-07	2.75e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	6.91e-07	2.75e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—NCOA1—prostate cancer	6.9e-07	2.75e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PHGDH—prostate cancer	6.89e-07	2.74e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—UMPS—prostate cancer	6.89e-07	2.74e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ARG2—prostate cancer	6.89e-07	2.74e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CYP1B1—prostate cancer	6.83e-07	2.72e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CYP19A1—prostate cancer	6.8e-07	2.71e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	6.78e-07	2.7e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—LRP2—prostate cancer	6.76e-07	2.69e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CYP2C18—prostate cancer	6.76e-07	2.69e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PLCB2—prostate cancer	6.76e-07	2.69e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—LDHB—prostate cancer	6.75e-07	2.69e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—AKR1C3—prostate cancer	6.75e-07	2.69e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PRKACB—prostate cancer	6.71e-07	2.67e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CYP17A1—prostate cancer	6.64e-07	2.65e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—P4HB—prostate cancer	6.63e-07	2.64e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CYP3A5—prostate cancer	6.63e-07	2.64e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GGT1—prostate cancer	6.62e-07	2.64e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PIK3CG—prostate cancer	6.59e-07	2.62e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—RXRA—prostate cancer	6.56e-07	2.61e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	6.55e-07	2.61e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—NCOA1—prostate cancer	6.52e-07	2.6e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—SLC22A1—prostate cancer	6.45e-07	2.57e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CYP19A1—prostate cancer	6.42e-07	2.56e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—TCN2—prostate cancer	6.4e-07	2.55e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—UCP3—prostate cancer	6.4e-07	2.55e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PDHA1—prostate cancer	6.4e-07	2.55e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GSTA3—prostate cancer	6.4e-07	2.55e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	6.38e-07	2.54e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—NCOA2—prostate cancer	6.33e-07	2.52e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—COMT—prostate cancer	6.32e-07	2.52e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GSTP1—prostate cancer	6.29e-07	2.51e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—SULT2A1—prostate cancer	6.29e-07	2.5e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—INS—prostate cancer	6.24e-07	2.48e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—RXRA—prostate cancer	6.2e-07	2.47e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—ITPR1—prostate cancer	6.19e-07	2.47e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—MED12—prostate cancer	6.18e-07	2.46e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GNG5—prostate cancer	6.14e-07	2.44e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—CREBBP—prostate cancer	6.11e-07	2.43e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—SLC22A3—prostate cancer	6.11e-07	2.43e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—HSD3B1—prostate cancer	6.11e-07	2.43e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—SLC5A5—prostate cancer	6.04e-07	2.41e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	6.03e-07	2.4e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—COMT—prostate cancer	5.97e-07	2.38e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GSTP1—prostate cancer	5.94e-07	2.37e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—NCOA3—prostate cancer	5.91e-07	2.35e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CYP2E1—prostate cancer	5.9e-07	2.35e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—TBXAS1—prostate cancer	5.85e-07	2.33e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GSTA4—prostate cancer	5.85e-07	2.33e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—TYMS—prostate cancer	5.85e-07	2.33e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—ITPR1—prostate cancer	5.85e-07	2.33e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—NQO1—prostate cancer	5.83e-07	2.32e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	5.81e-07	2.31e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PIK3CD—prostate cancer	5.79e-07	2.31e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GSTM1—prostate cancer	5.78e-07	2.3e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—EP300—prostate cancer	5.75e-07	2.29e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—TH—prostate cancer	5.75e-07	2.29e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	5.71e-07	2.28e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GSTA2—prostate cancer	5.71e-07	2.27e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CYP3A4—prostate cancer	5.69e-07	2.27e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—LPL—prostate cancer	5.68e-07	2.26e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	5.66e-07	2.25e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—HPGDS—prostate cancer	5.64e-07	2.25e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—SULT1A1—prostate cancer	5.64e-07	2.25e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ABCG5—prostate cancer	5.64e-07	2.25e-05	CbGpPWpGaD
Flutamide—AR—Gene Expression—MYC—prostate cancer	5.63e-07	2.24e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CYP2C19—prostate cancer	5.6e-07	2.23e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CYP1B1—prostate cancer	5.59e-07	2.23e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—TYMS—prostate cancer	5.53e-07	2.2e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GSTA1—prostate cancer	5.5e-07	2.19e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CYP1A1—prostate cancer	5.48e-07	2.18e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GSTT1—prostate cancer	5.47e-07	2.18e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ACHE—prostate cancer	5.47e-07	2.18e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—NOS3—prostate cancer	5.47e-07	2.18e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GSTM1—prostate cancer	5.46e-07	2.18e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—HSD3B2—prostate cancer	5.44e-07	2.17e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GSTO1—prostate cancer	5.44e-07	2.17e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—NAT2—prostate cancer	5.44e-07	2.17e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—ERCC2—prostate cancer	5.44e-07	2.17e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GGT1—prostate cancer	5.42e-07	2.16e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CYP2A6—prostate cancer	5.41e-07	2.15e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	5.38e-07	2.15e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—LPL—prostate cancer	5.36e-07	2.14e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—NCOA1—prostate cancer	5.33e-07	2.13e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—AKR1C3—prostate cancer	5.26e-07	2.09e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CYP19A1—prostate cancer	5.26e-07	2.09e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PRKACB—prostate cancer	5.23e-07	2.08e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PLCB2—prostate cancer	5.22e-07	2.08e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CYP2C18—prostate cancer	5.22e-07	2.08e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—LRP2—prostate cancer	5.22e-07	2.08e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CYP17A1—prostate cancer	5.18e-07	2.06e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—ERCC2—prostate cancer	5.14e-07	2.05e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—P4HB—prostate cancer	5.12e-07	2.04e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—MTHFR—prostate cancer	5.11e-07	2.04e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	5.11e-07	2.03e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—RXRA—prostate cancer	5.07e-07	2.02e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PIK3CB—prostate cancer	5.05e-07	2.01e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PPARA—prostate cancer	5.01e-07	2e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PTGS2—prostate cancer	5e-07	1.99e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—SLC22A1—prostate cancer	4.98e-07	1.98e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	4.94e-07	1.97e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—NCOA2—prostate cancer	4.93e-07	1.97e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—COMT—prostate cancer	4.89e-07	1.95e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GSTP1—prostate cancer	4.86e-07	1.94e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—SULT2A1—prostate cancer	4.85e-07	1.93e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—MTHFR—prostate cancer	4.83e-07	1.92e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ITPR1—prostate cancer	4.79e-07	1.91e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—MED12—prostate cancer	4.77e-07	1.9e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PPARA—prostate cancer	4.74e-07	1.89e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GNG5—prostate cancer	4.74e-07	1.89e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CAV1—prostate cancer	4.71e-07	1.88e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	4.71e-07	1.87e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—SLC5A5—prostate cancer	4.71e-07	1.87e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CYP2E1—prostate cancer	4.6e-07	1.83e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—NCOA3—prostate cancer	4.56e-07	1.82e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—NQO1—prostate cancer	4.54e-07	1.81e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—TYMS—prostate cancer	4.52e-07	1.8e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—TH—prostate cancer	4.48e-07	1.78e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GSTM1—prostate cancer	4.47e-07	1.78e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CAV1—prostate cancer	4.45e-07	1.77e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	4.45e-07	1.77e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CYP3A4—prostate cancer	4.43e-07	1.77e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	4.41e-07	1.76e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—LPL—prostate cancer	4.39e-07	1.75e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PTEN—prostate cancer	4.36e-07	1.74e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CYP1B1—prostate cancer	4.36e-07	1.74e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—HPGDS—prostate cancer	4.35e-07	1.73e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CYP2C19—prostate cancer	4.32e-07	1.72e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PIK3CG—prostate cancer	4.29e-07	1.71e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	4.25e-07	1.69e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CYP1A1—prostate cancer	4.24e-07	1.69e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GSTT1—prostate cancer	4.22e-07	1.68e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ACHE—prostate cancer	4.22e-07	1.68e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GGT1—prostate cancer	4.22e-07	1.68e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ERCC2—prostate cancer	4.2e-07	1.67e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CYP2A6—prostate cancer	4.17e-07	1.66e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—EP300—prostate cancer	4.16e-07	1.66e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—NCOA1—prostate cancer	4.16e-07	1.66e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CYP19A1—prostate cancer	4.1e-07	1.63e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—INS—prostate cancer	4.06e-07	1.62e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—AKR1C3—prostate cancer	4.06e-07	1.62e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PIK3CG—prostate cancer	4.06e-07	1.62e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PRKACB—prostate cancer	4.04e-07	1.61e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CYP17A1—prostate cancer	4e-07	1.59e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CREBBP—prostate cancer	3.98e-07	1.59e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—RXRA—prostate cancer	3.95e-07	1.58e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—MTHFR—prostate cancer	3.95e-07	1.57e-05	CbGpPWpGaD
Flutamide—AR—Gene Expression—AKT1—prostate cancer	3.9e-07	1.55e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PPARA—prostate cancer	3.88e-07	1.54e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	3.85e-07	1.53e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—INS—prostate cancer	3.84e-07	1.53e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—COMT—prostate cancer	3.81e-07	1.52e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—NCOA2—prostate cancer	3.81e-07	1.52e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GSTP1—prostate cancer	3.79e-07	1.51e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PIK3CD—prostate cancer	3.77e-07	1.5e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CREBBP—prostate cancer	3.76e-07	1.5e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ITPR1—prostate cancer	3.73e-07	1.49e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	3.67e-07	1.46e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CAV1—prostate cancer	3.64e-07	1.45e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—SLC5A5—prostate cancer	3.63e-07	1.45e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PIK3CD—prostate cancer	3.57e-07	1.42e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—NOS3—prostate cancer	3.56e-07	1.42e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CYP2E1—prostate cancer	3.55e-07	1.41e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—TYMS—prostate cancer	3.52e-07	1.4e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—NQO1—prostate cancer	3.51e-07	1.4e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GSTM1—prostate cancer	3.48e-07	1.39e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.48e-07	1.39e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—TH—prostate cancer	3.46e-07	1.38e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—LPL—prostate cancer	3.42e-07	1.36e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—NOS3—prostate cancer	3.37e-07	1.34e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CYP1B1—prostate cancer	3.36e-07	1.34e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PIK3CG—prostate cancer	3.32e-07	1.32e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CYP1A1—prostate cancer	3.3e-07	1.32e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PIK3CB—prostate cancer	3.29e-07	1.31e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ERCC2—prostate cancer	3.27e-07	1.3e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PTGS2—prostate cancer	3.26e-07	1.3e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GGT1—prostate cancer	3.26e-07	1.3e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—NCOA1—prostate cancer	3.21e-07	1.28e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CYP19A1—prostate cancer	3.16e-07	1.26e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—INS—prostate cancer	3.14e-07	1.25e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PIK3CB—prostate cancer	3.11e-07	1.24e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PTGS2—prostate cancer	3.08e-07	1.23e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—MTHFR—prostate cancer	3.08e-07	1.23e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CREBBP—prostate cancer	3.08e-07	1.23e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PIK3CA—prostate cancer	3.08e-07	1.23e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—RXRA—prostate cancer	3.05e-07	1.22e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PPARA—prostate cancer	3.02e-07	1.2e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—COMT—prostate cancer	2.94e-07	1.17e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GSTP1—prostate cancer	2.93e-07	1.17e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PIK3CD—prostate cancer	2.92e-07	1.16e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ITPR1—prostate cancer	2.88e-07	1.15e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PTEN—prostate cancer	2.84e-07	1.13e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CAV1—prostate cancer	2.84e-07	1.13e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—NOS3—prostate cancer	2.76e-07	1.1e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—TYMS—prostate cancer	2.72e-07	1.08e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.71e-07	1.08e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—EP300—prostate cancer	2.71e-07	1.08e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GSTM1—prostate cancer	2.69e-07	1.07e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PTEN—prostate cancer	2.69e-07	1.07e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—LPL—prostate cancer	2.64e-07	1.05e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PIK3CG—prostate cancer	2.59e-07	1.03e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—EP300—prostate cancer	2.56e-07	1.02e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CYP1A1—prostate cancer	2.55e-07	1.02e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PIK3CB—prostate cancer	2.54e-07	1.01e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ERCC2—prostate cancer	2.53e-07	1.01e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PTGS2—prostate cancer	2.52e-07	1e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—AKT1—prostate cancer	2.51e-07	1e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—INS—prostate cancer	2.45e-07	9.75e-06	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CREBBP—prostate cancer	2.4e-07	9.55e-06	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—MTHFR—prostate cancer	2.38e-07	9.46e-06	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PPARA—prostate cancer	2.33e-07	9.29e-06	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PIK3CD—prostate cancer	2.27e-07	9.06e-06	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PTEN—prostate cancer	2.2e-07	8.76e-06	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CAV1—prostate cancer	2.19e-07	8.73e-06	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—NOS3—prostate cancer	2.15e-07	8.55e-06	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—EP300—prostate cancer	2.1e-07	8.35e-06	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PIK3CA—prostate cancer	2.01e-07	7.99e-06	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PIK3CG—prostate cancer	2e-07	7.95e-06	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PIK3CB—prostate cancer	1.98e-07	7.9e-06	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PTGS2—prostate cancer	1.96e-07	7.82e-06	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PIK3CA—prostate cancer	1.89e-07	7.55e-06	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—INS—prostate cancer	1.89e-07	7.53e-06	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CREBBP—prostate cancer	1.85e-07	7.37e-06	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.75e-07	6.99e-06	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PTEN—prostate cancer	1.71e-07	6.82e-06	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—NOS3—prostate cancer	1.66e-07	6.6e-06	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—AKT1—prostate cancer	1.64e-07	6.53e-06	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—EP300—prostate cancer	1.63e-07	6.51e-06	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PIK3CA—prostate cancer	1.55e-07	6.18e-06	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—AKT1—prostate cancer	1.55e-07	6.17e-06	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.53e-07	6.09e-06	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PTGS2—prostate cancer	1.52e-07	6.04e-06	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PTEN—prostate cancer	1.32e-07	5.27e-06	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—AKT1—prostate cancer	1.27e-07	5.05e-06	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—EP300—prostate cancer	1.26e-07	5.02e-06	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PIK3CA—prostate cancer	1.21e-07	4.81e-06	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—AKT1—prostate cancer	9.87e-08	3.93e-06	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PIK3CA—prostate cancer	9.32e-08	3.71e-06	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—AKT1—prostate cancer	7.62e-08	3.03e-06	CbGpPWpGaD
